Connecting the World

Through Quality Products and Services

ABOUT US

Amorisha Empires LLP

Amorisha Empires LLP was established in April 2024. Dr. Sayan Dutta Gupta is the founder and director of the company. The main objective of the LLP is to carry trading, import and export of cosmetics, medical equipment, food products, nutraceuticals, textiles, and Indigenous products like tulsi, clove, etc., and to assist customers across the globe in setting up business ventures in India.

Global Trade
Expertise

Quality
Assurance

Innovation
& Growth

Client-Centric Approach

India’s DSDDS LLP and Amorisha empires LLP expand global outreach with 250,000 USD investment proposal: An example of Scientists turn entrepreneurs, taking research from labs to market

India’s Amorisha Empires LLP, a company specializing in export, import, and business solutions, and Dr. Sayan’s Drug Discovery Solutions LLP, focused on new drug discovery, are significantly expanding their global footprint with a substantial investment plan of $250,000 over the next year. This notable investment within just one year of their establishment highlights a promising future for both companies. Their first major agreement is with Microalgae Ask US (MAUS) in South Korea, which involves exporting research outcomes from KIST Gangneung Institute of Natural Products, including fucoxanthin and C. vulgaris-based cosmetics—an innovative first for India. Additionally, they have secured a commitment of $100,000 from venture capitalists for further investment.

MAUS has also agreed to partner with Dr. Sayan’s Drug Discovery Solutions LLP (DSDDS) to commercially synthesize fucoxanthin and its novel derivatives using advanced methodologies. This will help in particular meet the global demand of fucoxanthin which is expected to grow with a compound annual growth rate (CAGR) of 3.9% from 2024-2032, ultimately reaching 41 million USD.

The partnership was further extended to include transferring technology from Korea to India to harness microalgae for carbon dioxide absorption, a development with the potential to revolutionize pollution control in India. Overall, an investment of approximately $250,000 is planned for the coming year.

The company’s primary focus is on leveraging the potential of microalgae across various sectors, including pharmaceuticals, cosmetics, and environmental management. Dr. Sayan Dutta Gupta, founder and director of the company, remarked, “These ventures demonstrate the pathway for scientists to transition into entrepreneurship through the lab-to-market concept. I extend my gratitude to Dr. Pan Cheol Ho, Principal Research Scientist at KIST Gangneung Institute of Natural Products and Co-CEO of Microalgae Ask US, for his visionary support.”